NT‐proBNP and changes in cognition and global brain structure: The Rotterdam Study

Abstract

AbstractObjectiveTo investigate the association between N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) and changes in cognition and global brain structure.MethodsIn the Rotterdam Study, baseline NT‐proBNP was assessed at baseline from 1997 to 2008. Between 1997 and 2016, participants without dementia or stroke at baseline (n = 9566) had repeated cognitive tests (every 3–6 years) for global cognitive function, executive cognitive function, fine manual dexterity, and memory. Magnetic resonance imaging of the brain was performed repeatedly at re‐examination visits between 2005 and 2015 for 2607 participants to obtain brain volumes, focal brain lesions, and white matter microstructural integrity as measures of brain structure.ResultsAmong 9566 participants (mean age 65.1 ± 9.8 years), 5444 (56.9%) were women, and repeated measures of cognition were performed during a median follow‐up time of 5.5 (range 1.1–17.9) years, of whom 2607 participants completed at least one brain imaging scan. Higher levels of NT‐proBNP were associated with a faster decline of scores in the global cognitive function (p value = 0.003) and the Word‐Fluency test (p value = 0.003) but were not related to a steeper deterioration in brain volumes, global fractional anisotropy, and mean diffusivity, as indicators of white matter microstructural integrity, or focal brain lesions.ConclusionsHigher baseline NT‐proBNP levels were associated with a faster decline in cognition; however, no association with global brain structure was found.